Navigation Links
Evaluation of standard liver volume formula for Chinese adults

Living donor liver transplantation (LDLT) has been used to alleviate the shortage of available liver donors. Accurate estimation of the standard liver volume (SLV) of the living donor and recipient is crucial. Scholars of different countries established several SLV formulae from clinical data, but which formula was the most accurate for Chinese adults has remained unclear.

A research article to be published on August 28, 2009 in the World Journal of Gastroenterology, addresses this question. The research team led by Prof. Lu-Nan Yan from West China Hospital, Sichuan University evaluated reported SLV formulae using data of 76 cases of LDLT from January 2008 to April 2009.

The results demonstrated that the Chengdu formula was reliable by its applicability in LDLT. Statistical analysis showed that the Fan formula tended to underestimate SLV. The Heinemann, Urata, Vauthey, and Lee formulae overestimated SLV.

With national multicenter data in the future, the Chengdu formula for SLV can be improved. That may be applied to the evaluation of Chinese donors and recipients for LDLT.


Contact: Lai-Fu Li
World Journal of Gastroenterology

Page: 1

Related medicine news :

1. Sinovacs H1N1 Vaccine Passes Experts Evaluation Organized by SFDA
2. Drug Companies Often Unprepared For REMS Evaluation, Expert Warns
3. WellPoints Contribution To Drug Formulary Evaluation Standards Highlighted in ISPOR Publication
4. Patients with moderate to severe periodontitis need evaluation for heart disease risk
5. Evaluation shows $167 million investment improves community mental health system, but many still in need
6. More stringent evaluation on the use of generic medications in thoracic transplantation
7. QLT announces positive results from the evaluation of Visudyne(R) combination therapy
8. Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
9. Pennsylvania DEP Releases Evaluation of Air Quality Program
10. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
11. Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: